Influenza Infections after Hematopoietic Stem Cell Transplantation: Risk Factors, Mortality, and the Effect of Antiviral Therapy | Zendy

W. Garrett Nichols | Zendy; Katherine A. Guthrie | Zendy; Lawrence Corey | Zendy; Michael Boeckh | Zendy

Open Access

Influenza Infections after Hematopoietic Stem Cell Transplantation: Risk Factors, Mortality, and the Effect of Antiviral Therapy

Author(s) -

W. Garrett Nichols,

Katherine A. Guthrie,

Lawrence Corey,

Michael Boeckh

Publication year - 2004

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/425004

Subject(s) - medicine , hematopoietic stem cell transplantation , pneumonia , transplantation , stem cell , immunology , hematopoietic cell , hematopoietic stem cell , haematopoiesis , intensive care medicine , genetics , biology

Community-acquired respiratory viruses, such as influenza virus, are thought to be major causes of morbidity and mortality in patients who had undergone hematopoietic stem cell transplantation (HSCT). Risk factors for acquisition, progression to pneumonia, and the effect of antiviral therapy are unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research